Hormonal Responses to a Mixed Meal in People With Cystic Fibrosis
University of Cincinnati · with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NCT06163482
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–45 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 61
- US sites recruiting
- 1
- Study start
- March 28, 2023
- Record last updated
- August 25, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
In this exploratory study, the hormonal responses to a mixed meal will be examined in people with cystic fibrosis. The aim of this study is to find correlates with impaired glucose tolerance that is associated with this population.
Being studied: Mixed meal
Conditions: Cystic Fibrosis
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Diagnosed with cystic fibrosis
- Aged 18 to 45 years
- Males and females of any race and ethnicity
- Receiving highly effective CFTR modular therapy
Exclusion Criteria
- Transplant recipient
- Acute lung function decline or exacerbation within the last 3 months
- Use of systemic glucocorticoids
- Pregnancy
- Known liver disease that would be expected to significantly impact metabolic variable as interpreted by a study doctor
- The presence of any other disease or condition, as interpreted by any one of the study doctors, that would be expected to confound the responses to liquid mixed meal or make participation in the study dangerous to the individual
- People who are cognitively impaired
- People who do not speak English
- For CFRD patients, a daily insulin requirement that exceeds 0.8 U/kg/day
- Any prior history of diabetic ketoacidosis.
Recruiting US locations
University of Cincinnati
Cincinnati, OH 45267-0547
Site contact: Jason Winnick, PhD · 513-558-4437 · jason.winnick@uc.edu
Study contacts (from the official record)
- Jason Winnick, PhD · 513-558-4437 · jason.winnick@uc.edu
- Shana Warner, PhD · 513-558-5545 · warners3@ucmail.uc.edu
Similar studies in Ohio
All diabetes studies in Ohio →- RecruitingHealthy volunteersEarly Phase 1
Effect of C-peptide on Hypoglycemic Counterregulation
University of Cincinnati
- Location
- Cincinnati, OH
- Eligibility basics
- Ages 18–40
- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Columbus, OH + 55 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingPhase 2
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
Biomea Fusion Inc.
- Location
- Canton, OH + 19 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
Hanmi Pharmaceutical Company Limited
- Location
- Columbus, OH + 19 other US sites
- Eligibility basics
- Ages 18–75